IL17A and non-small cell lung carcinoma: Many scholars have reported that the expression increase of IL-17 in the cancer tissues can improve cell proliferation resulting in cancer growth [11,12] or elevating MMP2 and MMP9 production leading to NSCLC metastasis [13].